Mr Tilo Brandis
Tilo Brandis studied mechanical engineering at the Technical Universities of Braunschweig and Hamburg-Harburg as well as business administration at the University of Stirling before moving into management consulting. He has held General Management and CEO roles at Siemens transportation and automation divisions, for 11 years, and has held the position of managing director at Rail-One, Track-Tec and B2X Care Solutions.
Mr Brandis has extensive experience in international management and mergers and acquisitions.
Mr Heinrich Emden
Heinrich Emden holds a Master’s degree in Computer Science and has worked for BodyTel since 2013. He coordinates all internal and external developer teams and is responsible for the constant evolution and development of the BodyTel System. Prior to joining BodyTel, Heinrich gained valuable experience at several multinational organisations including IBM, Continental AG, Symrise and ATOS. During his tenure at these organisations, Heinrich’s role was largely focused on telecommunication and information technology development. Heinrich’s professional expertise relevantly encompasses the upcoming “Big Data”, data warehousing and mobile application industries.
Mr Mark Talbot
Mark Talbot has been involved in the delivery of technology projects for over 25 years. This has seen him working for several multinationals such as Bechtel, Alcoa, Broadspectrum and Ford. Mark was instrumental in the development of the Imunexus core strategy and implementation whilst sitting on the board. Mark has been involved in other Bio tech companies including his role as a non-executive director at Liquitab systems.
After seeing the need for a bridge from the inventor to the commercial world, Mark’s interest in new start-up ventures began 15 years ago with his involvement in the development of concept ideas when working for a small boutique consultancy.
Mr Francesco Cannavo
Francesco Cannavo is an experienced public company director with significant business and investment experience working with companies operating across various industries, and has been instrumental in assisting several listed and unlisted companies achieve their growth strategies through the raising of investment capital and the acquisition of assets.
Francesco is an entrepreneur with a strong network of investors and industry contacts in
the public company sector throughout the Asia-Pacific region and has extensive experience
in capital raisings, investment activities and IPO’s. Francesco is currently a non-executive director
of ASX-listed company, WONHE Multimedia Commerce Ltd (ASX:WMC).
Dr Philip Sion Bekhor
Incoming Non-Executive Director
Dr Bekhor is to be appointed as a non-executive director of the Company following completion of the Offer. Dr Bekhor is a graduate of the University of Melbourne and a Fellow of the Australasian College of Dermatologists. He trained both in Melbourne and Toronto, Canada. He is a specialist in procedural dermatology, which involves the laser and surgical management of skin disorders including cosmetic dermatology.
In 1982, Dr Bekhor was the first dermatologist in Victoria to use lasers in the management of birthmarks. In 1988, he was appointed the founding Director of the Laser Unit at the Royal Children’s Hospital to direct treatment with the then newly released Candela Pulsed Dye Laser. This was the first laser able to safely treat children with port wine stains and similar lesions. The Laser Unit at the RCH is a world recognised treatment, training and research centre.
In 1993, Dr Bekhor established LASER ASSOCIATES OF VICTORIA, a private, specialist supervised laser clinic.
In addition to laser therapy, Dr Bekhor is particularly interested in those newly evolving cosmetic procedures that are safe and effective with minimal downtime, such as superficial skin peels, fat transfer, injections of natural and synthetic “filler” substances, and wrinkle reducing muscle relaxants. He believes that these safe, simple approaches have, in many cases, replaced laser resurfacing and surgery, both of which have longer recovery times and involve more risk.
Dr Bekhor is a specialist Mohs Micrographic surgeon – one of a small group of dermatologic surgeons qualified to perform this specific method of skin cancer removal which achieves tumour removal with the minimum disfigurement. Mohs surgery is performed at the Skin and Cancer Foundation in Carlton, Victoria.